Stay updated on ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial
Sign up to get notified when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.

Latest updates to the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page
- CheckyesterdayChange DetectedLocations section updated with new site listings for US (California, Colorado, Connecticut, Florida, Kansas, Michigan, Nevada, New York, North Carolina, Pennsylvania, Virginia, Wisconsin) and Canada (Alberta, Ontario). The revision label changed from v3.3.2 to v3.3.3 and the page's location headings were reorganized (removing the separate state/province subheadings).SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedFooter shows Revision: v3.3.2, replacing v3.3.1; no study content or functionality was changed.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; no substantive changes to study details or page layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedThe government funding status notice/banner was removed from the page, removing the instruction to check opm.gov for updates.SummaryDifference0.3%

- Check52 days agoChange DetectedThis page update appears limited to administrative details (e.g., last update date) and minor formatting changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference2%

Stay in the know with updates to ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.